BioArctic signed the first deal for its “brain transporter” with Bristol Myers Squibb late last year. The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to ...

Chancellor Rachel Reeves is hoping the sun will shine on a 66-mile strip between Britain's top two universities which she ...

Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned.  ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Moderna shares fell 3% in premarket trading after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...